RSS   Newsletter   Contact   Advertise with us

Revance Therapeutics appoints Roman G. Rubio as SVP

Staff writer | Newark, Ca., USA | March 16, 2016
Roman G. RubioMarch 16, 2016, Newark, Ca., USA - Revance Therapeutics, a biotechnology company, announced the appointment of Roman G. Rubio as senior vice president of clinical development.
Dr. Rubio comes to Revance from Avalanche Biotechnologies where he was Senior Vice President of Translational Medicine. Prior to Avalanche, he served more than 11 years at Genentech, ascending through a number of clinical and development management roles to Global Head of Ophthalmology.

Dr. Rubio has an MBA in Health Care Management and Finance from The Wharton School, University of Pennsylvania, and received his Doctor of Medicine from University of California, San Francisco.

Dr. Rubio completed a Master of Science, Health and Medical Sciences from the University of California, Berkeley, and has a Bachelor of Science, Biological Sciences from the University of Notre Dame.